ReviewSpringerPlus2016
Multicentric reticulohistiocytosis (MRH): case report with review of literature between 1991 and 2014 with in depth analysis of various treatment regimens and outcomes.
Review in SpringerPlus, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Upadacitinib-Induced Remission in Multicentric Reticulohistiocytosis: Expanding the Therapeutic Role of JAK Inhibition.International journal of molecular sciences · 2026Article
- The Value of High-Frequency Ultrasound in the Evaluation of Cutaneous Rosai-Dorfman Disease: A Case Series and Literature Review.Diagnostics (Basel, Switzerland) · 2026Article
- Multicentric reticulohistiocytosis post-COVID-19: a case report.AME case reports · 2024Article
- A case report of multicentric reticulohistiocytosis with atypical cutaneous presentation.Frontiers in immunology · 2024Article
- Article
- Multicentric reticulohistiocytosis after severe COVID-19 infection.JAAD case reports · 2023Article
- Multicentric Reticulohistiocytosis Associated with an Early Form of Systemic Lupus Erythematosus: A Case Report of a Rare Disease, with Mini Review of the Literature.Journal of clinical medicine · 2022Review
- Successful Treatment of a Patient with Rheumatoid Arthritis and Comorbid Multicentric Reticulohistiocytosis.Rheumatology and immunology research · 2022Article
- Multicentric reticulohistiocytosis with prominent skin lesions and arthritis: A case report.World journal of clinical cases · 2022Article
- [Multicentric reticulohistiocytosis: A case report].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2021Article
- The combined prevalence of classified rare rheumatic diseases is almost double that of ankylosing spondylitis.Orphanet journal of rare diseases · 2021Article
- Reddish-brown papules and nodules on the hands.JAAD case reports · 2021Article
- Multicentric Reticulohistiocytosis Exhibiting Positive HLA-B*07 and HLA-B*08: A Case Report.Medicina (Kaunas, Lithuania) · 2020Article
- Multicentric reticulohistiocytosis: A case report with response to adalimumab.Clinical case reports · 2020Article
- Targetable driver mutations in multicentric reticulohistiocytosis.Haematologica · 2020Article
- Thalidomide, A Rational Agent for Treatment of Multicentric Reticulohistiocytosis.Dermatology case reports · 2019Article
- Multicentric reticulohistiocytosis: a case report.BMC research notes · 2018Article
- The utility of FDG-PET/CT imaging in the evaluation of multicentric reticulohistiocytosis: A case report.Medicine · 2018Article
- Looks Can Be Deceiving: A Case Report on Multicentric Reticulohistiocytosis Successfully Treated with Rituximab.Cureus · 2017Article
- Multicentric Reticulohistiocytosis with Dermatomyositis-like Eruptions.Internal medicine (Tokyo, Japan) · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multicentric reticulohistiocytosis is a rare disease affecting skin and joints primarily and rarely other organs. We present a case report of this disease and an extensive review of the literature. We reviewed the data between 1991 and 2014 and extracted 52 individual cases. Only articles in English were chosen after checking for relevance. The articles were studies and data was extracted into excel spread sheets and later used to compute such variables like frequency, mean and percentage of distribution of various clinical manifestations. The treatments used in these articles were critically analyzed and graded for their relative efficacy for skin and joint manifestations. The grades were 0 = worse, 1 = no benefit/condition remained same, 2 = improvement without resolution, and 3 = resolution. This article also reports the demographic, clinical, laboratory and pathological data from the reviewed articles. Authors attempted to discuss the findings of this review in depth to help manage this condition and proposed a treatment algorithm to help clinicians approach this rare and challenging disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.